Craig Davis

Arryx, Inc. develops holographic optical trapping technology. Its technology is used for optically controlled measurement and manipulation in biological and biomedical research as well as in the physical and material sciences. Arryx offers both stand-alone and turnkey solutions for Holo-Tweezers, as well as kit-based packages for the implementation of holographic optical trapping technology. The company was founded in 2000 and is headquartered in Chicago, IL.

ExaDigm, Inc. develops and manufactures wireless credit card and wired terminals. It provides point-of-sale, network conversion, and wireless connectivity equipment and solutions for businesses worldwide. The firm's electronic payment solutions include countertop terminals, mobile terminals, and integrated payment systems. It also provides network connectivity solutions, such as cellular wireless gateways. The company was founded by Dean H. Cha in 2000 and is headquartered in Santa Ana, CA.

Capital Growth Systems II, Inc. operates as holding company with interest in manufacturing communication equipment. The firm mainly manufactures electronic computers telephone communication products. Its services include certain voice applications, consulting solutions, remote network management and proprietary software services. The company was founded in 2003 and is located in Glendale Heights. IL.

Advanced Diamond Technologies, Inc. develops thin films of ultrananocrystalline diamond technology. The firm develops and applies diamond films for electronic, mechanical, industrial and biomedical applications. Its products include UNCD Wafers, UNCD Components, Diamonox Cells, UNCD Probes and UNCD Sensor Substrates. The company was founded by Neil D. Kane, John Carlisle and Orlando Auciello in December 2003 and is headquartered in Romeoville, IL.

Part of Lumos Pharma, Inc., BioProtection Systems Corp. is a company that manufactures biological products. The company is based in Ames, IA.

Part of Incyte Corp., Maxia Pharmaceuticals, Inc. develops pharmaceutical products based on molecule drug discovery techniques. The company is based in San Diego, CA. The company was founded by David Perryman, Xian Ping Lu. Maxia Pharmaceuticals was acquired by Incyte Corp. on February 19, 2003 for $42.30 million.

Northwestern University is a private institution founded in 1851 to serve the Northwest Territory, an area that now includes the states of Ohio, Indiana, Illinois, Michigan, Wisconsin and parts of Minnesota. Northwestern has three campuses

The Urban Land Institute operates as a non-commercial research organization. It provides leadership in the responsible use of land and in creating and sustaining thriving communities worldwide. The company was founded on December 14, 1936 and is headquartered in Washington, DC.

Healthios Capital Markets LLC provides financial advisory services. The private company is based in Northbrook, IL and has subsidiaries in Thailand and Singapore. The company was founded by Fritz Reichenbach.

Australian Institute of Co. Directors is a non-profit organization that provides leadership on director issues. It offers governance education, director development, and advocacy. The organization was founded in January 1, 1990 and is headquartered in Sydney, Australia.

Association for Corporate Growth, Inc. is a global organization founded in 1954 by Kenneth S. Berryman and David H. Brenner. The non-profit company is based in Chicago, IL and has subsidiaries in the United Kingdom, Netherlands, Canada, and the United States. The company's mission is to drive middle-market growth and it serves 90,000 investors, executives, lenders, and advisers to growing middle-market companies. The company's core focus is on middle-market M&A, with more than 25 years of sell-side and buy-side advisory experience, closing more than 200 transactions with a combined value of more than $1 billion. The company also publishes Middle Market Growth, the official publication of the Association for Corporate Growth, which includes a print magazine, website, weekly e-newsletter, and daily newsfeed. The CEO of the company since 2019 is Brent A. Baxter.

VHT, Inc. provides visual marketing services to the real estate industry. It offers real estate photography services, video property tours, glossy prints, media distribution and image management services and multi-media presentations. The company was founded by Brian Balduf and Brannon Lambert in 1998 and is headquartered in Rosemont, IL.

OrthoScan, Inc. is a holding company, which engages in the development and manufacture of orthopedic surgery equipment. It provides Orthicon-HD Mini C-Arm, which is used for fluoroscopic imaging of the extremities in orthopedic surgery and digital diagnostic imaging. The company was founded by Larry Grossman and in 2002 and is headquartered in Scottsdale, AZ.

Illinois Venture Capital Association engages in providing services such as education, networking, industry events, roundtable discussions and government lobbying. The company is headquartered in Chicago, IL.

TheraFuse, Inc. designs and develops non-contact optical flow sensors for use in the commercial, industrial and medical applications. It offers delivery systems for insulin, pain medication, and protein drugs, disposable insulin patches for diabetics; and sprinkler hypodermic needles for sub-Q fluid delivery in drug pens. The company was founded in 2001 and is headquartered in Carlsbad, CA.

Illinois Technology Association engages in the provision of programs and services focused on development, visibility and talent attraction. It focuses on the growth acceleration of technology companies where members benefit from access to programs in three key areas: development, talent, and visibility. The company was founded by Terry Howerton and Fred Hoch in 2005 and is headquartered in Chicago, IL.

LaSalle Investment Management Asia Pte Ltd. (LaSalle Asia) is a global real estate investment manager headquartered in Singapore. The firm is a subsidiary of Jones Lang Lasalle Property Consultants Pte Ltd., which is ultimately owned by Jones Lang LaSalle, Inc. (NYSE: JLL) in the US. LaSalle Asia offers a wide range of real estate investment solutions designed to meet investor needs. Their diverse client base consists of various institutional investors across the globe, such as pension funds, insurance companies, sovereign wealth funds and endowments.

IGL Pharma, Inc. provides health care services. The company was founded in 2016 by Keith R. Frank and Jamie Simon and is headquartered in Angleton, TX.

Part of Jones Lang LaSalle, Inc., LaSalle Investment Management Australia Pty Ltd. provides investment management services. The company is based in Sydney, Australia.

ImmunSYS, Inc. is a clinical stage biopharmaceutical company focused on the development of cancer immunotherapy products. The company was founded by Eamonn P. Hobbs and Charles J. Link Jr. in March 2018 and is headquartered in Fort Lauderdale, FL.

Viewpoint Molecular Targeting, Inc. develops pharmaceutical drugs for diagnostic imaging and therapy for cancer. The firm?s radiopharmaceutical drugs are designed to specifically localize in cancerous tissues in the human body. The company was founded by Frances L. Johnson, Michael K. Schultz and Heyward H. Coleman in 2008 and is headquartered in Coralville, IA.

SynVivo, Inc. is an American company that specializes in microfluidic organ-on-chip technology. The private company's platform allows for the real-time study of cellular behavior, drug delivery, and drug discovery.

Syncromune, Inc. is a clinical-stage biopharmaceutical company that is dedicated to developing an in situ platform technology optimized for metastatic solid tumor cancers. The company is based in Fort Lauderdale, FL. The company is currently developing Sync-T™, a novel combination drug/device treatment platform that aims to achieve high response rates with potentially curative efficacy. The therapy is designed to synchronize in situ neoantigen T cell education and immunostimulation via intratumoral/locoregional infusion, with the goal of enabling the immune system to recognize and attack cancer throughout the body. The first two candidates, SV-101 and SV-102, are currently in investigator-initiated phase 1 trials. Link. The company was founded in 2020 by Charles J. Eamonn P. Hobbs has been the CEO of the company since 2020.